跳至主要内容
临床试验/ITMCTR2100004405
ITMCTR2100004405招募中未知

A prospective randomized controlled clinical trial of Pingmu Decoction combined with acupuncture in the treatment of non-active thyroid-related ophthalmopathy

onghua Hospital, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Patients who meet the diagnostic criteria of TCM and Western medicine;
  • 2. Patients aged 19-70 years;
  • 3. Patients who refused surgery;
  • 4. Patients with go history and normal serum thyroid hormone levels (FT3, FT4) for at least two months;
  • 5. Those patients with informed consent, who have good compliance and are willing to accept treatment.

排除标准

  • 1. Other causes of exophthalmos: myopic exophthalmos, primary orbital tumor, orbital inflammatory pseudotumor, eye metastases and other diseases;
  • 2. Mental patients;
  • 3. Patients with severe primary and secondary cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic system diseases, and hyperthyroid crisis tendency;
  • 4. Pregnant or lactating women.

研究者

发起方
onghua Hospital, Shanghai University of Traditional Chinese Medicine

相似试验